It was a long road, but happy that it’s finally out. The scientific results of our SMILE trial showing that MS patients have a blunted response to UVB light. In them its effects stay in the skin and do not translate systemically. https://t.co/6DLkOLEHnt
Happy to share our new paper on the effects of Cladribine on the T and Bcell repertoire and how they translate to clinical efficacy. https://t.co/HqLSabIiks
Our new study shows that natalizumab treatment gap not only changes serum biomarkers (e.g. sVCAM-1), but also (subsequently) CSF composition, suggesting that renewed immune infiltration into the CNS and other tissues might play a role in reducing PML risk. https://t.co/gNpTt2p64f
Our paper is out: the first genetic treatment response biomarker in MS. A finding only made possible by AIRRseq. This was a truly collaborative effort with @jsabatino37@hwiendl@AdaptiveBiotech and is a huge step towards personalized medicine.
https://t.co/GHxzSr2oft
The next chapter in our continued effort to understand EBV and MS: Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation https://t.co/GKc7pG3WFz
Rare diseases need some attention, too.
Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy: Cell Reports Medicine https://t.co/mfshB29dUr
Glad to finally be able to showcase our #TCR-#epitope annotation tool DETECT and the cool results we have gotten with it at the @airr_community#AIRRC7 conference!
And as of now you can use it yourself!
Transcriptomics reveals CSF cellular composition in multiple sclerosis but detects no viral RNA
New scientific commentary by Nicholas Schwab https://t.co/iRx81utwVe
I wrote a commentary about a new MS CSF scRNAseq study that was recently published in @Brain1878 Transcriptomics reveals CSF cellular composition in multiple sclerosis but detects no viral RNA https://t.co/F1JRbJxQTh
The new special issue of #ScienceTranslationalMedicine is out! This issue features a collection of studies and articles exploring frontiers in #neuroimmunology and the role of the immune system in neurological conditions such as Parkinson's disease.
https://t.co/FyevVOndrS
I wrote a review in @ScienceTM with my long-time collaborator @hwiendl about what we can learn about CNS immunity when we look closely at patients treated with interventions that target BBB trafficking. https://t.co/4vBXNmHOoF
A new episode of #OnAIRR - the podcast of the AIRR Community is available. We discuss AIRR-seq, machine learning and disease diagnostics with @zazius, @ScottBoydLab. Subscribe and listen in your favourite app or grab the episode here: https://t.co/btLfI1hi0P
A new episode of #OnAIRR - the podcast of the AIRR Community is available. Prof Xenophon Papademetris, @YaleRadiology, USA, introduces Software as a Medical Device. Subscribe and listen in your favourite app or grab the episode here: https://t.co/btLfI1hi0P